Dr Graham Lappin

Graham Lappin has a PhD in biochemistry and has been in research for over 30 years. Specialising in the use of isotopes to study the metabolic fate of xenobiotics, he has held three adjunct professorships (Duke University, North Carolina, USA, Medical University of Vienna, Austria and the University of Lincoln, UK). He was also an advisor at the Karolinska Institutet in Sweden. He was a Fellow of the UK’s Royal Society of Chemistry and Fellow of the Institute of Biology (now Royal Society of Biology). He was an Emeritus member of the American Society of Clinical Pharmacology and Therapeutics and Chief Scientific Officer for accelerator mass spectroscopy facilities based in York, UK and Maryland, USA. He became an academic at the University of Lincoln (UK) in 2012 where he founded a BSc in Pharmaceutical Science, and where he still does some part-time teaching.